← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Glycoscientific, Llc
Athens, GA
$5,523,413
Total funding
12
Grants
Funding over time
peak $1.2M · FY2011–23$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,523,413 · 12
By mechanism
N43$1,403,142 · 3
R41$1,388,915 · 4
R44$1,110,831 · 1
R43$923,430 · 3
R42$697,095 · 1
Investigators at Glycoscientific, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
CREATING ANTIBODIES TO ENABLE THE STUDY OF MYCOBACTERIUM TUBERCULOSIS INFECTIONS IN GUINEA PIGS$653,191
N43 · FY2019 · AI
Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig$600,000
N43 · FY2023 · AI
Development of Isotopically Labeled Glycoproteins for use as Internal Standards$352,644
R42 · FY2020 · GM
Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research$350,000
R44 · FY2018 · GM
Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research$350,000
R44 · FY2019 · GM
Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research$349,999
R44 · FY2017 · GM
Antibodies to O-GlcNAc modified histones for chromatin biology and epigenetic res$349,180
R43 · FY2014 · GM
Development of Isotopically Labeled Glycoproteins for use as Internal Standards$344,451
R42 · FY2021 · GM
Site-specific O-GlcNAc MAbs: New Tools for Glycoproteomics$322,669
R41 · FY2012 · GM
Site-specific O-GlcNAc MAbs: New Tools for Glycoproteomics$301,575
R41 · FY2013 · GM
Recognition of O-GlcNAc Modified Proteins Using Site-Specific Antibodies$275,767
R43 · FY2023 · HL
Development of Isotopically Labeled Glycoproteins for use as Internal Standards$270,251
R41 · FY2015 · GM
Isotopically Labeled Heparan Sulfate Glycosaminoglycan Disaccharides for use as Internal Standards$252,114
R41 · FY2020 · GM
Generation of antibodies to monitor Notch O-fucosylation in vivo$242,306
R41 · FY2016 · GM
Development of Site-specific Arg-GlcNAc Antibodies$150,000
R43 · FY2019 · GM
SBIR TOPIC 294 PHASE I - DEVELOPMENT OF GLYCOSYLATION-SPECIFIC RESEARCH REAGENTS$149,951
N43 · FY2011 · CA
Development of Site-specific Arg-GlcNAc Antibodies$148,483
R43 · FY2020 · GM
Development of Site-specific O-GlcNAc Antibodies for Epigenetic Research$60,832
R44 · FY2018 · GM